BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8837329)

  • 1. Minocycline and the thyroid: antithyroid effects of the drug, and the role of thyroid peroxidase in minocycline-induced black pigmentation of the gland.
    Taurog A; Dorris ML; Doerge DR
    Thyroid; 1996 Jun; 6(3):211-9. PubMed ID: 8837329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of action of the thioureylene antithyroid drugs.
    Taurog A
    Endocrinology; 1976 Apr; 98(4):1031-46. PubMed ID: 1278093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential inhibition of thyroxine and 3,5,3'-triiodothyronine formation by propylthiouracil and methylmercaptoimidazole in thyroid peroxidase-catalyzed iodination of thyroglobulin.
    Engler H; Taurog A; Dorris ML
    Endocrinology; 1982 Jan; 110(1):190-7. PubMed ID: 7053983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism for the anti-thyroid action of minocycline.
    Doerge DR; Divi RL; Deck J; Taurog A
    Chem Res Toxicol; 1997 Jan; 10(1):49-58. PubMed ID: 9074802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The selenium analog of 6-propylthiouracil. Measurement of its inhibitory effect on type I iodothyronine deiodinase and of its antithyroid activity.
    Taurog A; Dorris ML; Hu WX; Guziec FS
    Biochem Pharmacol; 1995 Mar; 49(5):701-9. PubMed ID: 7887985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of thioureylene antithyroid drugs in the rat: possible inactivation of thyroid peroxidase by propylthiouracil.
    Shiroozu A; Taurog A; Engler H; Dorris ML
    Endocrinology; 1983 Jul; 113(1):362-70. PubMed ID: 6861708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antithyroid agents 6-propyl-2-thiouracil and 1-mehtyl-2-mercaptoimidazole on human thyroid iodine peroxidase.
    Nagasaka A; Hidaka H
    J Clin Endocrinol Metab; 1976 Jul; 43(1):152-8. PubMed ID: 947933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of 35S- and 14C-labeled propylthiouracil in a model in vitro system containing thyroid peroxidase.
    Taurog A; Dorris ML; Guziec FS; Uetrecht JP
    Endocrinology; 1989 Jun; 124(6):3030-7. PubMed ID: 2656249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coupling of iodotyrosine catalyzed by human thyroid peroxidase in vitro.
    Sugawara M
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1069-75. PubMed ID: 3838997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A reexamination of the proposed inactivation of thyroid peroxidase in the rat thyroid by propylthiouracil.
    Taurog A; Dorris ML
    Endocrinology; 1989 Jun; 124(6):3038-42. PubMed ID: 2656250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloperoxidase-catalyzed iodination and coupling.
    Taurog A; Dorris ML
    Arch Biochem Biophys; 1992 Jul; 296(1):239-46. PubMed ID: 1318692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methimazole and propylthiouracil increase cellular thyroid peroxidase activity and thyroid peroxidase mRNA in cultured porcine thyroid follicles.
    Sugawara M; Sugawara Y; Wen K
    Thyroid; 1999 May; 9(5):513-8. PubMed ID: 10365684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of simultaneous iodination and coupling catalyzed by thyroid peroxidase.
    Taurog A; Dorris ML; Doerge DR
    Arch Biochem Biophys; 1996 Jun; 330(1):24-32. PubMed ID: 8651700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible and irreversible inhibition of thyroid peroxidase-catalyzed iodination by thioureylene drugs.
    Engler H; Taurog A; Luthy C; Dorris ML
    Endocrinology; 1983 Jan; 112(1):86-95. PubMed ID: 6847836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of inactivation of thyroid peroxidase by thioureylene drugs.
    Engler H; Taurog A; Nakashima T
    Biochem Pharmacol; 1982 Dec; 31(23):3801-6. PubMed ID: 6186257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-species analysis of thyroperoxidase inhibition by xenobiotics demonstrates conservation of response between pig and rat.
    Paul KB; Hedge JM; Macherla C; Filer DL; Burgess E; Simmons SO; Crofton KM; Hornung MW
    Toxicology; 2013 Oct; 312():97-107. PubMed ID: 23959146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of potency differences among thyroid peroxidase (TPO) inhibitors to induce developmental toxicity and other thyroid gland-linked toxicities in humans and rats.
    Motonaga K; Ota M; Odawara K; Saito S; Welsch F
    Regul Toxicol Pharmacol; 2016 Oct; 80():283-90. PubMed ID: 27350053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine structural aspects of the black thyroid induced by minocycline, and the effects of a low iodine diet, propylthiouracil, thyroxine tablet and TSH, on the black discoloration of the rat thyroid.
    Kurosumi M; Fujita H
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 48(3):219-27. PubMed ID: 2859695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents.
    Abuid J; Larsen PR
    J Clin Invest; 1974 Jul; 54(1):201-8. PubMed ID: 4134836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of 35S- and 14C-labeled 1-methyl-2-mercaptoimidazole in vitro and in vivo.
    Taurog A; Dorris ML; Guziec FS
    Endocrinology; 1989 Jan; 124(1):30-9. PubMed ID: 2535809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.